Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

Treatment Frequency and Dosing Interval of Ranibizumab and Aflibercept for Neovascular Age-Related Macular Degeneration in Routine Clinical Practice in the USA

Bibliographic Details
Main Authors: Ferreira, Alberto, Sagkriotis, Alexandros, Olson, Melvin, Lu, Jingsong, Makin, Charles, Milnes, Fran
Format: Online
Language:English
Published: Public Library of Science 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514835/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514835/

Similar Items